| scholarly article | Q13442814 |
| P50 | author | D Smith | Q67212553 |
| Michael S. Okun | Q42595404 | ||
| P2093 | author name string | Kelly Sullivan | |
| Israt Jahan | |||
| Fernando L Vale | |||
| Theresa Zesiewicz | |||
| Andrew S Resnick | |||
| Amber Miller | |||
| Teresita Malapira | |||
| P2860 | cites work | Mood and motor effects of thalamic deep brain stimulation surgery for essential tremor. | Q48327972 |
| Brain penetration effects of microelectrodes and deep brain stimulation leads in ventral intermediate nucleus stimulation for essential tremor | Q48491499 | ||
| Long-term evaluation of deep brain stimulation of the thalamus | Q48581388 | ||
| Essential tremor: treatment options | Q48602274 | ||
| Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor | Q48856959 | ||
| Deep brain stimulation for essential tremor | Q49024450 | ||
| How common is essential tremor? | Q50275940 | ||
| Low-dose topiramate (topamax) in the treatment of essential tremor | Q50276665 | ||
| Pregabalin (Lyrica) in the treatment of essential tremor | Q50277805 | ||
| Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor. | Q51084620 | ||
| Thalamic deep brain stimulation: effects on the nontarget limbs. | Q53801575 | ||
| How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor | Q56047951 | ||
| Essential tremor: Treatment with propranolol | Q67427871 | ||
| Clonidine in the treatment of essential tremor | Q68243413 | ||
| Essential tremor | Q73075571 | ||
| Bilateral thalamic stimulation for the treatment of essential tremor | Q73114333 | ||
| Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor | Q73532955 | ||
| Essential tremor: the beginning of a new era | Q73942309 | ||
| The number and nature of emergency department encounters in patients with deep brain stimulators | Q33157913 | ||
| How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings | Q33523378 | ||
| Antihypertensive agents and risk of Parkinson's disease, essential tremor and dementia: a population-based prospective study (NEDICES). | Q33678373 | ||
| Essential tremor: clinical characteristics | Q33943214 | ||
| Pharmacologic treatment of essential tremor. | Q33943223 | ||
| Surgical treatment of essential tremor | Q33943228 | ||
| Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology | Q33988002 | ||
| How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor | Q34021342 | ||
| Treatment of patients with essential tremor | Q34025450 | ||
| Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor | Q34144957 | ||
| Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs. general neurologists | Q34238588 | ||
| Diagnosis and management of essential tremor and dystonic tremor | Q34625978 | ||
| Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. | Q34643972 | ||
| Treatment of essential tremor with propranolol | Q34701459 | ||
| Benefits and Risks of Pharmacological Treatments for Essential Tremor | Q35123386 | ||
| Essential tremor: differential diagnosis and current therapy | Q35189759 | ||
| Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor | Q35472119 | ||
| Deep brain stimulation and essential tremor | Q35751055 | ||
| Pharmacological treatment of disabling tremor | Q36082064 | ||
| Lessons learned in deep brain stimulation for movement and neuropsychiatric disorders. | Q36525761 | ||
| Update on pathogenesis and treatment of essential tremor | Q36874874 | ||
| Deep brain stimulation and tremor | Q37131276 | ||
| Pharmacotherapy of essential tremor : an overview of existing and upcoming agents | Q37322233 | ||
| Deep brain stimulation for essential tremor: a systematic review | Q37771924 | ||
| Blood flow responses to deep brain stimulation of thalamus | Q39407111 | ||
| Deep brain stimulation in the nucleus ventralis intermedius in patients with essential tremor: habituation of tremor suppression | Q39829944 | ||
| Overview of essential tremor | Q41765411 | ||
| Propranolol reduces variceal pressure and wall tension in schistosomiasis presinusoidal portal hypertension | Q43290754 | ||
| Randomized trial comparing primidone initiation schedules for treating essential tremor | Q43938526 | ||
| Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial. | Q46453924 | ||
| Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor. | Q48167354 | ||
| P577 | publication date | 2012-04-06 | |
| P1433 | published in | Tremor and other hyperkinetic movements | Q27723870 |
| P1476 | title | Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor | |
| P478 | volume | 2 |
Search more.